Lakeshore Biopharma Co, Stock Today
| LSBPW Stock | 0.04 0 3.90% |
Performance0 of 100
| Odds Of DistressOver 81
|
LakeShore Biopharma is selling for under 0.04 as of the 28th of November 2024; that is 3.90 percent increase since the beginning of the trading day. The stock's lowest day price was 0.04. LakeShore Biopharma has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. LakeShore Biopharma symbol was changed from YSBPW on 28th of May 2024. Equity ratings for LakeShore Biopharma Co, are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of August 2024 and ending today, the 28th of November 2024. Click here to learn more.
IPO Date 10th of August 2021 | Category Healthcare |
LakeShore Biopharma is entity of United States. It is traded as Stock on NASDAQ exchange. More on LakeShore Biopharma Co,
Moving against LakeShore Stock
LakeShore Stock Highlights
| Older Symbol | YSBPW | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CoCEO Board | Dave Chenn | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceutical Products, Biotechnology, Healthcare, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LakeShore Biopharma can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand LakeShore Biopharma's financial leverage. It provides some insight into what part of LakeShore Biopharma's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LakeShore Biopharma Co, (LSBPW) is traded on NASDAQ Exchange in USA. It is located in Building No. 2, Beijing, China, 102629 and employs 758 people. LakeShore Biopharma Co, was previously known as YS Biopharma Co, and was traded on NASDAQ Exchange under the symbol YSBPW. LakeShore Biopharma is listed under Pharmaceutical Products category by Fama And French industry classification. The company classifies itself under Healthcare sector and is part of Biotechnology industry.
LakeShore Biopharma generates negative cash flow from operations
Check LakeShore Biopharma Probability Of Bankruptcy
LakeShore Biopharma Historical Income Statement
LakeShore Stock Against Markets
LakeShore Biopharma Corporate Management
| Yuan Liu | Head Research | Profile | |
| Zenaida MD | Chief Officer | Profile | |
| Gang Li | Head Sales | Profile | |
| Zhiyuan Ran | Head Department | Profile |
Additional Tools for LakeShore Stock Analysis
When running LakeShore Biopharma's price analysis, check to measure LakeShore Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LakeShore Biopharma is operating at the current time. Most of LakeShore Biopharma's value examination focuses on studying past and present price action to predict the probability of LakeShore Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LakeShore Biopharma's price. Additionally, you may evaluate how the addition of LakeShore Biopharma to your portfolios can decrease your overall portfolio volatility.